Peyronie’s disease: A contemporary review of non-surgical treatmentFootnote

Peer review under responsibility of Arab Association of Urology.

References

• F.de la PeyronieSur quelques obstacles qui s’opposent à l’ejaculation naturelle de la semenceMem Acad Chir11743318
   Google Scholar
• J.P.MulhallS.D.CreechS.A.BoorjianS.GhalyE.D.KimA.Motyet alSubjective and objective analysis of the prevalence of Peyronie’s disease in a population of men presenting for prostate cancer screeningJ Urol171200423502353
   PubMed Web of Science ®Google Scholar
• R.Raanan TalM.S.HallB.AlexJ.ChoiJ.P.MulhallPeyronie’s disease in teenagersJ Sex Med92012302308
   Google Scholar
• D.VernetG.NolazcoL.CantiniT.R.MageeA.QianJ.Rajferet alEvidence that osteogenic progenitor cells in human tunica albuginea originate from stem cells. Implications for Peyronie’s diseaseBiol Reprod73200511991210
   PubMed Web of Science ®Google Scholar
• M.Del CarloA.A.ColeL.A.LevineDifferential calcium independent regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases by interleukin-1beta and transforming growth factor-beta in Peyronie’s plaque fibroblastsJ Urol179200824472455
   PubMed Web of Science ®Google Scholar
• C.NelsonC.DiblasioM.KendirciW.HellstromP.GuhringJ.MulhallThe chronology of depression and distress in men with Peyronie’s diseaseJ Sex Med8200819851990
   Google Scholar
• R.RosenJ.CataniaT.LueS.AlthofJ.HenneW.Hellstromet alImpact of Peyronie’s disease on sexual and psychosocial functioning: qualitative findings in patients and controlsJ Sex Med5200819771984
   PubMed Web of Science ®Google Scholar
• U.SchwarzerF.SommerT.KlotzM.BraunB.ReifenrathU.EngelmannThe prevalence of Peyronie’s disease: results of a large surveyBJU Int882001727730
   PubMed Web of Science ®Google Scholar
• J.C.LaRochelleL.A.LevineA survey of primary-care physicians and urologists regarding Peyronie’s diseaseJ Sex Med4200711671173
   PubMed Web of Science ®Google Scholar
• J.P.MulhallJ.SchiffP.GuhringAn analysis of the natural history of Peyronie’s diseaseJ Urol175200621152118
   PubMed Web of Science ®Google Scholar
• A.KadiogluO.SanliT.AkmanO.CanguvenM.AydinF.Akbulutet alFactors affecting the degree of penile deformity in Peyronie disease: an analysis of 1001 patientsJ Androl322011502508
   PubMedGoogle Scholar
• A.CasabéA.BecharaG.ChelizW.De BonisH.ReyRisk factors of Peyronie’s disease. What does our clinical experience show?J Sex Med82011518523
   PubMed Web of Science ®Google Scholar
• M.F.UstaT.J.BivalacquaZ.TokatliF.RiveraK.H.GulkesenS.C.Sikkaet alStratification of penile vascular pathologies in patients with Peyronie’s disease and in men with erectile dysfunction according to age: a comparative studyJ Urol1722004259262
   Web of Science ®Google Scholar
• E.ChungL.De YoungG.B.BrockPenile duplex ultrasonography in men with Peyronie’s disease: is it veno-occlusive dysfunction or poor cavernosal arterial inflow that contributes to erectile dysfunction?J Sex Med8201134463451
   Web of Science ®Google Scholar
• D.RalphN.Gonzalez-CadavidV.MironeS.PerovicM.SohnM.UstaL.LevineThe management of Peyronie’s disease: evidence-based 2010 guidelinesJ Sex Med7201023592374
   PubMed Web of Science ®Google Scholar
• A.I.El-SakkaPrevalence of Peyronie’s disease among patients with erectile dysfunctionEur Urol492006564569
   PubMed Web of Science ®Google Scholar
• A.I.El-SakkaK.A.TayebPeyronie’s disease in diabetic patients being screened for erectile dysfunctionJ Urol174200510261030
   PubMed Web of Science ®Google Scholar
• G.La PeraE.S.PescatoriM.CalabreseE.S.PescatoriM.CalabreseA.Boffiniet alPeyronie’s disease: prevalence and association with cigarette smoking. A multicenter population-based study in men aged 50–69 yearsEur Urol402001525530
   PubMed Web of Science ®Google Scholar
• S.M.LarsenL.A.LevineReview of non-surgical treatment options for Peyronie’s diseaseInt J Impot Res242012110
   PubMed Web of Science ®Google Scholar
• E.G.ValenteD.VernetM.G.FerriniA.QianJ.RajferN.F.Gonzalez-Cadavidl-arginine and phosphodiesterase (PDE) inhibitors counteract fibrosis in the Peyronie’s fibrotic plaque and related fibroblast culturesNitric Oxide92003229244
   PubMed Web of Science ®Google Scholar
• M.ShiraziA.R.HaghpanahM.BadieeM.A.AfrasiabiS.HaghpanahEffect of intralesional verapamil for treatment of Peyronie’s disease: a randomized single-blind, placebo-controlled studyInt Urol Nephrol412009467471
   PubMed Web of Science ®Google Scholar
• J.AggelerS.M.FrischZ.WerbChanges in cell shape correlate with collagenase gene expression in rabbit synovial fibroblastsJ Cell Biol98198416621671
   PubMed Web of Science ®Google Scholar
• M.RothO.EickelbergE.KohlerP.ErneL.H.BlockCa2+ channel blockers modulate metabolism of collagens within the extracellular matrixProc Natl Acad Sci USA93199654785482
   PubMed Web of Science ®Google Scholar
• M.S.AndersonT.V.ShankeyT.LubranoJ.P.MulhallInhibition of Peyronie’s plaque fibroblast proliferation by biologic agentsInt J Impot Res12Suppl. 32000S2531
   Google Scholar
• E.ChungF.GarciaL.De YoungM.SolomonG.B.BrockA comparative study of the efficacy of intralesional verapamil versus normal saline injection in a novel Peyronie disease animal model: assessment of immunohistopathological changes and erectile function outcomeJ Urol1892013380384
   PubMed Web of Science ®Google Scholar
• S.M.LarsenL.A.LevinePeyronie’s disease: review of nonsurgical treatment optionsUrol Clin North Am382011195205
   PubMed Web of Science ®Google Scholar
• W.J.HellstromM.KendirciR.MaternY.CockerhamL.MyersS.C.Sikkaet alSingle-blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon alpha-2B for minimally invasive treatment for Peyronie’s diseaseJ Urol1762006394398
   PubMed Web of Science ®Google Scholar
• M.GelbardL.I.LipschultzJ.TursiT.SmithG.KaufmanL.A.LevinePhase 2b study of clinical efficacy and safety of collagenase Clostridium histolyticum in patients with Peyronie’s diseaseJ Urol187201222682274
   PubMed Web of Science ®Google Scholar
• A.PalmieriC.ImbimboN.LongoF.FuscoP.VerzeA.Malettaet alA first prospective, randomized, double-blind, placebo-controlled clinical trial evaluating extracorporeal shock wave therapy for the treatment of Peyronie’s diseaseEur Urol562009363370
   PubMed Web of Science ®Google Scholar
• S.ChitaleM.MorseyL.SwiftK.SethiaLimited shock wave therapy vs sham treatment in men with Peyronie’s disease. Results of a prospective randomized controlled double-blind trialBJU Int106201013521356
   PubMed Web of Science ®Google Scholar
• A.A.RaheemG.GaraffaT.A.RaheemM.DixonA.KayesN.Christopheret alThe role of vacuum pump therapy to mechanically straighten the penis in Peyronie’s diseaseBJU Int106201011781180
   PubMed Web of Science ®Google Scholar
• F.J.AlenghatD.E.IngberMechanotransduction: all signals point to cytoskeleton, matrix, and integrinsSci STKE1211920026
   Google Scholar
• B.A.AlmanS.P.NaberR.M.TerekW.A.JiranekM.J.GoldbergH.J.WolfePlatelet-derived growth factor in fibrous musculoskeletal disorders: a study of pathologic tissue sections and in vitro primary cell culturesJ Orthop Res1319956777
   PubMed Web of Science ®Google Scholar
• C.T.BrightonJ.R.FisherJrS.E.LevineJ.R.CorsettiT.ReillyA.S.Landsmanet alThe biochemical pathway mediating the proliferative response of bone cells to a mechanical stimulusJ Bone Joint Surg AM78199613371347
   PubMed Web of Science ®Google Scholar
• G.MoleaF.SchonauerF.BlasiProgressive skin extension: clinical and histological evaluation of a modified procedure using Kirschner wiresBr J Plast Surg521999205208
   PubMedGoogle Scholar
• G.BrandesA.MessinaE.RealeThe palmar fascia after treatment by the continuous extension technique for Dupuytren’s contractureJ Hand Surg Br191994528533
   PubMedGoogle Scholar
• L.A.LevineM.NewellF.L.TaylorPenile traction therapy for treatment of Peyronie’s disease: a single-center pilot studyJ Sex Med5200814681473
   PubMed Web of Science ®Google Scholar
• P.GonteroM.Di MarcoG.GiubileiR.BartolettiG.PappagalloA.Tizzaniet alUse of penile extender device in the treatment of penile curvature as a result of Peyronie’s disease. Results of a phase II prospective studyJ Sex Med62009558566
   PubMed Web of Science ®Google Scholar
• M.R.AbernS.LarsenL.A.LevineCombination of penile traction, intralesional verapamil, and oral therapies for Peyronie’s diseaseJ Sex Med92012288295
   PubMed Web of Science ®Google Scholar
• J.RybakD.PapagiannopoulosL.A.LevineA retrospective comparative study of traction therapy vs. no traction following tunica albuginea plication or partial excision and grafting for Peyronie’s disease: Measured lengths and patient perceptionsJ Sex Med9201223962403
   PubMed Web of Science ®Google Scholar